Human TNFRSF19 Protein (TNF-HM119)
Catalog: TNF-HM119
Order now get it on
| Product Description | Recombinant Human TNFRSF19 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Glu30-Leu170. |
Product Background |
A novel susceptibility gene TNFRSF19, which encodes an orphan member of the TNF receptor superfamily known to be associated with nasopharyngeal carcinoma (NPC) and lung cancer risk. TNFRSF19, a susceptibility gene for nasopharyngeal carcinoma and other cancers, functions as a potent inhibitor of the TGFβ signaling pathway. |
Product Category |
Recombinant Protein |
Target |
TNFRSF19 |
Gene/Protein ID |
Q9NS68-1 |
Species |
Human |
Exact Sequence |
Glu30-Leu170 |
| Molecular Weight | The protein has a predicted MW of 42.22 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Tris-Bis PAGE result. |
Product Tag |
C-hFc |
Express System |
HEK293 |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per ug by the LAL method. |
| Form | Lyophilized |
| Shipping | Shipped at ambient temperature. |
| Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Stability And Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
|
The purity of Human TNFRSF19 is greater than 95% as determined by SEC-HPLC. |
|
|
Human TNFRSF19 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. |
You may also be interested in
View more associated products